Pretreatment HIV Drug Resistance and the Molecular Transmission Network among HIV-positive Individuals in China in 2022: a Multicenter Observational Study (Preprint)
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pretreatment HIV Drug Resistance and the Molecular Transmission Network among HIV-positive Individuals in China in 2022: a Multicenter Observational Study (Preprint)
Authors
Keywords
-
Journal
JMIR Public Health and Surveillance
Volume -, Issue -, Pages -
Publisher
JMIR Publications Inc.
Online
2023-10-06
DOI
10.2196/50894
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Prevalence of Primary Drug Resistance Among Newly Diagnosed HIV-1-Infected Individuals in Hunan Province, China
- (2023) Xujian Cao et al. AIDS RESEARCH AND HUMAN RETROVIRUSES
- Epidemiology and Transmitted HIV-1 Drug Resistance among Treatment-Naïve Individuals in Israel, 2010–2018
- (2022) Tali Wagner et al. Viruses-Basel
- Molecular Network Analysis Reveals Transmission of HIV-1 Drug-Resistant Strains Among Newly Diagnosed HIV-1 Infections in a Moderately HIV Endemic City in China
- (2022) Bin Zhao et al. Frontiers in Microbiology
- Pre‐treatment and acquired antiretroviral drug resistance among people living with HIV in Tianjin, China
- (2022) Liying Gao et al. HIV MEDICINE
- Pretreatment drug resistance in people living with HIV: A large retrospective cohort study in Chongqing, China
- (2022) Min Liu et al. HIV MEDICINE
- Drug Resistance to HIV-1 Integrase Inhibitors Among Treatment-Naive Patients in Beijing, China
- (2022) Fengting Yu et al. Pharmacogenomics & Personalized Medicine
- Molecular Epidemiology and Trends in HIV-1 Transmitted Drug Resistance in Mozambique 1999–2018
- (2022) Nalia Ismael et al. Viruses-Basel
- Genetic network analysis of human immunodeficiency virus sexual transmission in rural Southwest China after the expansion of antiretroviral therapy: A population-based study
- (2022) Jin Chen et al. Frontiers in Microbiology
- Molecular transmission network of pretreatment drug resistance among human immunodeficiency virus-positive individuals and the impact of virological failure on those who received antiretroviral therapy in China
- (2022) Hongli Chen et al. Frontiers in Medicine
- HIV Drug Resistance Mutations Detection by Next-Generation Sequencing during Antiretroviral Therapy Interruption in China
- (2021) Miaomiao Li et al. Pathogens
- HIV Pretreatment Drug Resistance Trends in Mexico City, 2017–2020
- (2021) Claudia García-Morales et al. Pathogens
- Pretreatment HIV drug resistance in adults initiating antiretroviral therapy in China, 2017
- (2020) Rui-Hua Kang et al. Infectious Diseases of Poverty
- Pre-Treatment and Acquired Antiretroviral Drug Resistance among Persons Living with HIV in Four African Countries
- (2020) Trevor A Crowell et al. CLINICAL INFECTIOUS DISEASES
- Survey of pretreatment HIV drug resistance and genetic transmission network analysis among HIV patients in a high drug-use area of Southwest China
- (2019) Liu Lei et al. CURRENT HIV RESEARCH
- HIV-1 subtype diversity, drug resistance, and genetic transmission networks in men who have sex with men with virologic failure in antiretroviral therapy in Sichuan, China, 2011 to 2017
- (2019) Dan Yuan et al. MEDICINE
- Transmitted HIV drug resistance among individuals with newly diagnosed HIV infection
- (2019) Jingrong Ye et al. AIDS
- Natural presence of V179E and rising prevalence of E138G in HIV-1 reverse transcriptase in CRF55_01B viruses
- (2019) Yongjian Liu et al. INFECTION GENETICS AND EVOLUTION
- Pretreatment HIV drug resistance spread within transmission clusters in Mexico City
- (2019) Margarita Matías-Florentino et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- HIV Infection and Drug Resistance with Unsupervised Use of HIV Pre-Exposure Prophylaxis
- (2018) Jonathan E. Volk et al. AIDS RESEARCH AND HUMAN RETROVIRUSES
- Prevalence of pretreatment HIV drug resistance in Cameroon following a nationally representative WHO survey
- (2018) Gaëlle F Tchouwa et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- HIV-TRACE (TRAnsmission Cluster Engine): a Tool for Large Scale Molecular Epidemiology of HIV-1 and Other Rapidly Evolving Pathogens
- (2018) Sergei L Kosakovsky Pond et al. MOLECULAR BIOLOGY AND EVOLUTION
- Epidemiological surveillance of HIV-1 transmitted drug resistance among newly diagnosed individuals in Shijiazhuang, northern China, 2014–2015
- (2018) Xianfeng Wang et al. PLoS One
- Pretreatment HIV drug resistance among adults initiating ART in Namibia
- (2018) Negussie Taffa et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- HIV-1 subtype diversity, transmission networks and transmitted drug resistance amongst acute and early infected MSM populations from Coastal Kenya
- (2018) Amin S. Hassan et al. PLoS One
- Prevalence of Pre-antiretroviral-Treatment Drug Resistance by Gender, Age, and Other Factors in HIV-Infected Individuals Initiating Therapy in Kenya, 2013–2014
- (2017) Rachel A Silverman et al. JOURNAL OF INFECTIOUS DISEASES
- Transmitted HIV Drug Resistance Is High and Longstanding in Metropolitan Washington, DC
- (2016) Seble G. Kassaye et al. CLINICAL INFECTIOUS DISEASES
- Characteristics of Transmitted Drug-Resistant HIV-1 in Recently Infected Treatment-Naive Patients in Japan
- (2016) Junko Hattori et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Pretreatment HIV-1 drug resistance in Argentina: results from a surveillance study performed according to WHO-proposed new methodology in 2014–15
- (2016) E. Bissio et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Evolution and viral characteristics of a long-term circulating resistant HIV-1 strain in a cluster of treatment-naive patients
- (2013) L. M. Hofstra et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started